Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


27.08.2018

1 BMC Neurol
1 J Neural Transm (Vienna)
1 J Neurochem
2 Mov Disord
1 Nervenarzt
1 Neurochem Res
2 Neurol Clin Pract
1 Neurosci Lett
1 PLoS Med
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. WANG G, Cui HL, Liu J, Xiao Q, et al
    Current approaches for the management of Parkinson's disease in Chinese hospitals: a cross-sectional survey.
    BMC Neurol. 2018;18:122.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  2. ENGELS G, McCoy B, Vlaar A, Theeuwes J, et al
    Clinical pain and functional network topology in Parkinson's disease: a resting-state fMRI study.
    J Neural Transm (Vienna). 2018 Aug 21. pii: 10.1007/s00702-018-1916.
    PubMed     Text format     Abstract available


    J Neurochem

  3. GALLEA JI, Ambroggio EE, Vilcaes AA, James NG, et al
    Amyloid oligomerization of the Parkinson's disease related protein alpha-synuclein impacts on its curvature-membrane sensitivity.
    J Neurochem. 2018 Aug 24. doi: 10.1111/jnc.14573.
    PubMed     Text format     Abstract available


    Mov Disord

  4. WITEK N, Stebbins GT, Goetz CG
    What influences placebo and nocebo responses in Parkinson's disease?
    Mov Disord. 2018 Aug 22. doi: 10.1002/mds.27416.
    PubMed     Text format     Abstract available

  5. LERCHE S, Liepelt-Scarfone I, Wurster I, Schulte C, et al
    Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease.
    Mov Disord. 2018 Aug 22. doi: 10.1002/mds.27427.
    PubMed     Text format     Abstract available


    Nervenarzt

  6. HIRJAK D, Kubera KM, Bienentreu S, Thomann PA, et al
    [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 1 : Dystonia, akathisia und parkinsonism].
    Nervenarzt. 2018 Aug 20. pii: 10.1007/s00115-018-0582.
    PubMed     Text format     Abstract available


    Neurochem Res

  7. REKHA KR, Inmozhi Sivakamasundari R
    Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
    Neurochem Res. 2018 Aug 23. pii: 10.1007/s11064-018-2617.
    PubMed     Text format     Abstract available


    Neurol Clin Pract


  8. Erratum: A practical approach to detection and treatment of depression in Parkinson disease and dementia.
    Neurol Clin Pract. 2018;8:278.
    PubMed     Text format     Abstract available


  9. Erratum: What predicts falls in Parkinson disease? Observations from the Parkinson's Foundation Registry.
    Neurol Clin Pract. 2018;8:278.
    PubMed     Text format     Abstract available


    Neurosci Lett

  10. CHEN Y, Cao B, Chen X, Ou R, et al
    The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Neurosci Lett. 2018 Aug 22. pii: S0304-3940(18)30569.
    PubMed     Text format     Abstract available


    PLoS Med

  11. NAM GE, Kim SM, Han K, Kim NH, et al
    Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
    PLoS Med. 2018;15:e1002640.
    PubMed     Text format     Abstract available


    PLoS One

  12. CHOUDHURY GR, Daadi MM
    Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease.
    PLoS One. 2018;13:e0202770.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  13. TELKES I, Viswanathan A, Jimenez-Shahed J, Abosch A, et al
    Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 Aug 21. pii: 1810589115.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  14. ALEXOUDI A, Alexoudi I, Gatzonis S
    Parkinson's disease pathogenesis, evolution and alternative pathways: A review.
    Rev Neurol (Paris). 2018 Aug 18. pii: S0035-3787(17)30683.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: